The FFR-IQ software recently demonstrated a 92.2 percent sensitivity for non-invasive estimation of fractional flow reserve (FFRC) based on coronary CT angiography (CCTA) scans.
|Articles|September 9, 2008
Nuclear medicine dosing for kids varies widely
A Boston Children's Hospital survey of 16 selected procedures at 13 pediatric hospitals in North America found a wide variation in radiopharmaceutical doses administered during nuclear medicine exams. The report reveals a need for consensus among nuclear physicians on appropriate doses for young patients.
Advertisement
A Boston Children's Hospital survey of 16 selected procedures at 13 pediatric hospitals in North America found a wide variation in radiopharmaceutical doses administered during nuclear medicine exams. The report reveals a need for consensus among nuclear physicians on appropriate doses for young patients.
Lead author Dr. S. Ted Treves and colleagues tracked the minimum and maximum administered radiopharmaceutical dose as well as the protocols used to determine appropriate doses. They found variations in maximum dosage for some drugs by a factor of 10 and differences in minimum dose by as much as a factor of 20. Survey results appeared in the June issue of the Journal of Nuclear Medicine.
Advertisement
Related to this article
Catch up on the top radiology content of the past week.
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Can MRI-Based AI Have an Impact in Reducing Unnecessary Prostate Biopsies?
2
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
3
FDA Clears AI-Enabled FFR-IQ Software for Estimating Fractional Flow Reserve from CCTA
4
The Reading Room Podcast: A Closer Look at New Research on 177Lu-Edotreotide for Treating GEP-NETs
5